Guardado en:
Detalles Bibliográficos
Autores principales: Xu, Chenmeng, Wang, Rui, Li, Jia, Li, Xiaomin, Huang, Jianjun, Li, Deshang, Wang, Qianqian, Ma, Weijun, Dehaen, Wim, Chau, Ho-Fai, Fang, Yuyu, Huai, Qiyong
Formato: Artículo científico
Lenguaje:en
Publicado: Bioorganic & medicinal chemistry 2025
Materias:
Acceso en línea:https://pubmed.ncbi.nlm.nih.gov/40489915/
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1868266193683480578
author Xu, Chenmeng
Wang, Rui
Li, Jia
Li, Xiaomin
Huang, Jianjun
Li, Deshang
Wang, Qianqian
Ma, Weijun
Dehaen, Wim
Chau, Ho-Fai
Fang, Yuyu
Huai, Qiyong
author_facet Xu, Chenmeng
Wang, Rui
Li, Jia
Li, Xiaomin
Huang, Jianjun
Li, Deshang
Wang, Qianqian
Ma, Weijun
Dehaen, Wim
Chau, Ho-Fai
Fang, Yuyu
Huai, Qiyong
Xu, Chenmeng
Wang, Rui
Li, Jia
Li, Xiaomin
Huang, Jianjun
Li, Deshang
Wang, Qianqian
Ma, Weijun
Dehaen, Wim
Chau, Ho-Fai
Fang, Yuyu
Huai, Qiyong
collection PubMed - marine biology
contents Preparation of mitochondria-targeted camptothecin derivatives for the imaging and antiproliferation of colorectal cancer. Xu, Chenmeng Wang, Rui Li, Jia Li, Xiaomin Huang, Jianjun Li, Deshang Wang, Qianqian Ma, Weijun Dehaen, Wim Chau, Ho-Fai Fang, Yuyu Huai, Qiyong Humans Mitochondria Colorectal Neoplasms Cell Proliferation Camptothecin Apoptosis Structure-Activity Relationship Drug Screening Assays, Antitumor Antineoplastic Agents Molecular Structure HCT116 Cells Dose-Response Relationship, Drug Colorectal cancer ranks among the top causes of both cancer incidence and mortality, posing a severe threat to global health. Currently, chemotherapeutic drugs used for treating colorectal cancer, such as camptothecin (CPT) and its derivatives, are limited in their application due to gastrointestinal reactions and myelosuppression. Mitochondria-targeted therapy aims to deliver active drug molecules into the mitochondria via electrostatic adsorption, allowing them to exert their effects directly within the mitochondria while reducing side effects during treatment. In this work, we used camptothecin as the parent compound, then we synthesized three series of 13 camptothecin derivatives by attaching alkyl chains of different length to delocalized lipophilic cations such as triphenylphosphonium, F16 and rhodamine B. The in vitro cytotoxicity screening revealed that compounds 8a and 8c, which are connected to rhodamine B, showed significantly higher antiproliferative activity against HCT116 colorectal cancer cells than CPT. Furthermore, compound 8a exhibited lower toxicity towards normal liver cells. Cellular imaging experiments demonstrated excellent mitochondria-targeted abilities of compounds 8a and 8c. Flow cytometry analysis indicated that compound 8a can induce apoptosis in a concentration-dependent manner. Overall, compound 8a can be a potential anti-cancer agent for colorectal cancer.
format Artículo científico
id pubmed_40489915
institution PubMed
language en
publishDate 2025
publisher Bioorganic & medicinal chemistry
record_format pubmed
spellingShingle Preparation of mitochondria-targeted camptothecin derivatives for the imaging and antiproliferation of colorectal cancer.
Xu, Chenmeng
Wang, Rui
Li, Jia
Li, Xiaomin
Huang, Jianjun
Li, Deshang
Wang, Qianqian
Ma, Weijun
Dehaen, Wim
Chau, Ho-Fai
Fang, Yuyu
Huai, Qiyong
Humans
Mitochondria
Colorectal Neoplasms
Cell Proliferation
Camptothecin
Apoptosis
Structure-Activity Relationship
Drug Screening Assays, Antitumor
Antineoplastic Agents
Molecular Structure
HCT116 Cells
Dose-Response Relationship, Drug
Preparation of mitochondria-targeted camptothecin derivatives for the imaging and antiproliferation of colorectal cancer. Xu, Chenmeng Wang, Rui Li, Jia Li, Xiaomin Huang, Jianjun Li, Deshang Wang, Qianqian Ma, Weijun Dehaen, Wim Chau, Ho-Fai Fang, Yuyu Huai, Qiyong Humans Mitochondria Colorectal Neoplasms Cell Proliferation Camptothecin Apoptosis Structure-Activity Relationship Drug Screening Assays, Antitumor Antineoplastic Agents Molecular Structure HCT116 Cells Dose-Response Relationship, Drug Colorectal cancer ranks among the top causes of both cancer incidence and mortality, posing a severe threat to global health. Currently, chemotherapeutic drugs used for treating colorectal cancer, such as camptothecin (CPT) and its derivatives, are limited in their application due to gastrointestinal reactions and myelosuppression. Mitochondria-targeted therapy aims to deliver active drug molecules into the mitochondria via electrostatic adsorption, allowing them to exert their effects directly within the mitochondria while reducing side effects during treatment. In this work, we used camptothecin as the parent compound, then we synthesized three series of 13 camptothecin derivatives by attaching alkyl chains of different length to delocalized lipophilic cations such as triphenylphosphonium, F16 and rhodamine B. The in vitro cytotoxicity screening revealed that compounds 8a and 8c, which are connected to rhodamine B, showed significantly higher antiproliferative activity against HCT116 colorectal cancer cells than CPT. Furthermore, compound 8a exhibited lower toxicity towards normal liver cells. Cellular imaging experiments demonstrated excellent mitochondria-targeted abilities of compounds 8a and 8c. Flow cytometry analysis indicated that compound 8a can induce apoptosis in a concentration-dependent manner. Overall, compound 8a can be a potential anti-cancer agent for colorectal cancer.
title Preparation of mitochondria-targeted camptothecin derivatives for the imaging and antiproliferation of colorectal cancer.
topic Humans
Mitochondria
Colorectal Neoplasms
Cell Proliferation
Camptothecin
Apoptosis
Structure-Activity Relationship
Drug Screening Assays, Antitumor
Antineoplastic Agents
Molecular Structure
HCT116 Cells
Dose-Response Relationship, Drug
url https://pubmed.ncbi.nlm.nih.gov/40489915/